Finance

Lists
AYTU:NASDAQ
Aytu Biopharma Inc
$2.04
-1.45%
(-0.030) 1D
Oct 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AYTU...
Open
$2.05
High
$2.15
Low
$2.04
Mkt. cap
22.17M
Avg. vol.
41.97K
Volume
0.00
52-wk high
$3.06
52-wk low
$1.80
EPS
-$1.16
Beta
0.17
Shares outstanding
10.87M
No. of employees
76
Open
$2.05
High
$2.15
Low
$2.04
Mkt. cap
22.17M
Avg. vol.
41.97K
Volume
0.00
52-wk high
$3.06
52-wk low
$1.80
EPS
-$1.16
Beta
0.17
Shares outstanding
10.87M
No. of employees
76
News stories
From web sources and news partners
About Aytu Biopharma Inc
CEO-
Employees76
Founded2002
HeadquartersDenver, Colorado, United States
SectorPharmaceutical industry
Websiteaytubio.com
Analyst ratings
Based on 2 analysts giving stock ratings to AYTU in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for AYTU in the last 3 months.
Highest
Current $2.04
$7.00 (+243.14%)
Average
$7.00 (+243.14%)
Lowest
$7.00 (+243.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Buy
Reiterated
$7.00
+243.1%
09/24/2026
Thomas Flaten
Lake Street
Buy
Maintained
$7.00
+243.1%
09/23/2026
Edward Woo
Ascendiant
Buy
Maintained
$14.50
+610.8%
06/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
13.89M
15.16M
12.41M
16.11M
Cost of goods sold
4.70M
5.54M
4.81M
5.70M
Cost of revenue
4.70M
5.54M
4.81M
5.70M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.25M
11.07M
10.90M
10.42M
Operating expense
10.69M
11.59M
11.66M
11.19M
Total operating expenses
15.39M
17.14M
16.48M
16.88M
Operating income
-1.50M
-1.97M
-4.06M
-777.00K
Other non operating income
3.98M
-8.05M
-1.11M
1.16M
EBT including unusual items
1.96M
-10.58M
-5.61M
-4.00K
EBT excluding unusual items
1.96M
-10.58M
-5.61M
-4.00K
Income tax expense
-
-
10.00K
11.00K
Effective tax rate
-
-
-0.18%
-275.00%
Other operating expenses
-
-
-
-
Net income
1.96M
-10.58M
-5.62M
-15.00K
Net profit margin
14.15%
-69.79%
-45.27%
-0.09%
Earnings per share
-0.09
-0.23
-0.41
-0.06
Interest and investment income
-
-
-
-
Interest expense
-516.00K
-560.00K
-436.00K
-383.00K
Net interest expenses
-516.00K
-560.00K
-436.00K
-383.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-701.00K
-1.08M
-2.94M
344.00K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps